Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:47 PM
NCT ID: NCT02778867
Description: None
Frequency Threshold: 5
Time Frame: From informed consent to 30 days after the cessation of treatment
Study: NCT02778867
Study Brief: SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
1-Food Elimination Diet (1FED) Participants eliminate milk from the diet in Phase 1 1 Food Elimination Diet Therapy 0 None 0 67 1 67 View
6-Food Elimination Diet (6FED) Participants eliminate milk, egg, wheat, soy, nuts, fish from the diet in Phase 1 6 Food Elimination Diet Therapy 0 None 0 62 2 62 View
1FED Non-Responders (6FED) Participants that fail to respond to 1FED in Phase 1 eliminate milk, egg, wheat, soy, nuts, fish from the diet in Phase 2 6 Food Elimination Diet (after 1FED failure) 0 None 0 21 0 21 View
6FED Non-responders (SGC) Participants that fail to respond to 6FED in Phase 1 administer swallowed glucocorticoids (SGC) (Flovent HFA) 880 mcg twice daily in Phase 2 Fluticasone Propionate, 880 mcg twice daily (after 6FED failure) 0 None 1 11 4 11 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Suicidal ideation NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE (4.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Gastrointestinal Pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Diarrhea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Bronchial Infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (4.0) View
Adrenal insufficiency NON_SYSTEMATIC_ASSESSMENT Endocrine disorders CTCAE (4.0) View